Corpus Intelligence IC Memo — EASTERN PLUMAS HEALTH CARE 2026-04-26 15:42 UTC
IC Memo — EASTERN PLUMAS HEALTH CARE
Investment Committee Memorandum | CA | 9 beds | Grade D | EBITDA uplift $2.8M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

EASTERN PLUMAS HEALTH CARE

CCN 051300 | nan, CA | 9 beds | April 26, 2026
EBITDA BridgeData Room
D
Investability

1. Target Overview & Investment Thesis

EASTERN PLUMAS HEALTH CARE is a 9-bed community hospital in nan, CA with $37.8M in net patient revenue and a -0.7% operating margin. The hospital serves a payer mix of 82.5% Medicare, 0.0% Medicaid, and 17.5% commercial.

Thesis: Turnaround. Our ML models identify $2.8M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -0.7% to 6.6% (+736bps).

Net Revenue HCRIS$37.8M
Current EBITDA COMPUTED$-276K
Operating Margin COMPUTED-0.7%
Occupancy HCRIS24.5%
Revenue / Bed COMPUTED$4.2M
Net-to-Gross HCRIS81.6%
Distress Probability MLnan%

2. Market Context & Competitive Position

414
CA Hospitals
-4.9%
State Median Margin
21
Comparable Hospitals

CA has 414 Medicare-certified hospitals with a median operating margin of -4.9%. The target's margin of -0.7% places it above the state median. Among 21 size-comparable peers (4-18 beds), the median margin is -10.2%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (4-18), prioritizing same-state peers. 21 hospitals in the comp set.

HospitalStateBedsRevenueMargin
EASTERN PLUMAS HEALTH CARE (Target)CA9$37.8M-0.7%
PORTERVILLE DEVELOPMENTAL CENTCA17$193.6M-6.0%
SOUTHERN MONO HEALTH CARE DISTCA17$99.1M4.1%
JEWISH HOME FOR THE AGEDCA13$88.0M-48.0%
MEE MEMORIAL HOSPITALCA13$67.6M3.3%
JOYCE EISENBERG KEEFER MEDICALCA10$52.9M18.8%
MAYERS MEMORIAL HOSPITALCA16$41.7M-1.3%
WEST COVINA MEDICAL CENTERCA13$40.6M55.3%
MEE MEMORIAL HOSPITALCA13$36.3M-23.4%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $2.8M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$795K+210bp18mo
Cost to Collect4.5%2.5%$757K+200bp12mo
Denial Rate Reduction12.0%6.5%$749K+198bp12mo
A/R Days Reduction5200.0%3800.0%$461K+122bp9mo
Clean Claim Rate88.0%96.0%$24K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$795K
Cost to Collect
$757K
Denial Rate Reduction
$749K
A/R Days Reduction
$461K
Clean Claim Rate
$24K
Total EBITDA Uplift$2.8M
Current EBITDA$-276K
+ RCM Uplift+$2.8M
Pro Forma EBITDA$2.5M
Current Margin-0.7%
Pro Forma Margin6.6%
WC Released (1x)$1.5M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-425K$26.0M0.00x-100.0%
Base (11x exit)10.0x11.0x$-425K$28.5M0.00x-100.0%
Bull Case9.0x11.0x$-383K$37.6M0.00x-100.0%
Bull (12x exit)9.0x12.0x$-383K$40.9M0.00x-100.0%
Bear Case11.0x10.0x$-468K$12.2M0.00x-100.0%
Bear (11x exit)11.0x11.0x$-468K$13.3M0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion
MediumHeavy Medicare dependenceMedicare comprises 82.5% of days; rate updates may lag inflation. Mitigant: CDI/CMI lever directly increases Medicare reimbursement
MediumLow occupancyAt 24.5%, fixed costs are spread over fewer patient days. Mitigant: volume growth is an additional upside lever not modeled in base case

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 21 hospitals with 4-18 beds
  • Same-state prioritization (n=27)
  • Comp margins: P25=-48.0% / P50=-10.2% / P75=3.3%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.